D-Phe-Pro-Arg-Chloromethylketone: Its Potential Use in Inhibiting the Formation of
In Vitro Artifacts in Blood Collected During Tissue-Type Plasminogen Activator Thrombolytic
Therapy
Authors
M A Mohler
The Department of Genentech, Inc., South San Francisco, CA, USA
C J Refino
The Department of Genentech, Inc., South San Francisco, CA, USA
S A Chen
The Department of Genentech, Inc., South San Francisco, CA, USA
A B Chen
*
The Departments of Pharmacological Sciences and Medicinal and Analytical Chemistry,
South San Francisco, CA, USA
A J Hotchkiss
The Department of Genentech, Inc., South San Francisco, CA, USA
